Winner Medical Co., Ltd. (SHE:300888)
China · Delayed Price · Currency is CNY 30.67
-0.29 (-0.94%)
Jul 31, 2026, 3:04 PM CST
Winner Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 770.89 | 767.97 | 695.38 | 580.4 | 1,651 | 1,239 |
Depreciation & Amortization | 656.94 | 656.94 | 578.21 | 540.39 | 481.74 | 376.71 |
Other Amortization | 38.85 | 38.85 | 57.39 | 54.64 | 73.41 | 55.65 |
Loss (Gain) From Sale of Assets | -0.55 | -0.55 | -5.88 | -32.2 | -3.73 | -3.25 |
Asset Writedown & Restructuring Costs | 198.32 | 198.32 | 107.2 | 282.21 | 74.78 | 20.26 |
Loss (Gain) From Sale of Investments | -28.75 | -28.75 | -78.25 | -174.02 | -83.62 | -155.38 |
Provision & Write-off of Bad Debts | 9.61 | 9.61 | 4.58 | -3.06 | -4.95 | -3.39 |
Other Operating Activities | 205.23 | 109.99 | 171.58 | 201.08 | 380.52 | 46.16 |
Change in Accounts Receivable | 178.14 | 178.14 | -7.99 | 182.4 | 42.54 | -27.1 |
Change in Inventory | -137.29 | -137.29 | -238.09 | -53.1 | -73.53 | -473.63 |
Change in Accounts Payable | -125.26 | -125.26 | -36.98 | -578.42 | 526.25 | -289.57 |
Change in Other Net Operating Assets | 26.44 | 26.44 | 14.8 | 35.18 | -8 | 84.73 |
Operating Cash Flow | 1,764 | 1,666 | 1,266 | 1,063 | 2,983 | 871.69 |
Operating Cash Flow Growth | 47.12% | 31.60% | 19.04% | -64.36% | 242.26% | -81.72% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -766.22 | -647.91 | -900.89 | -753.07 | -1,199 | -743.27 |
Sale of Property, Plant & Equipment | 37.86 | 37.87 | 25.75 | 108.04 | 63.2 | 190.93 |
Cash Acquisitions | - | - | -767.59 | -147.08 | -1,677 | - |
Investment in Securities | -134.49 | 226.51 | -2,663 | 1,588 | -1,161 | 846.96 |
Other Investing Activities | 105.69 | 107.92 | 193.5 | 234.36 | 155.71 | 184.19 |
Investing Cash Flow | -757.17 | -275.62 | -4,112 | 1,030 | -3,818 | 478.81 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | - | 32.09 | - | - | - |
Long-Term Debt Issued | - | 2,819 | 1,761 | 2,153 | 2,277 | - |
Total Debt Issued | 2,728 | 2,819 | 1,793 | 2,153 | 2,277 | - |
Short-Term Debt Repaid | - | -6.59 | -44.2 | -183.51 | -119.43 | -150 |
Long-Term Debt Repaid | - | -3,430 | -1,810 | -3,084 | -396.64 | -233.45 |
Total Debt Repaid | -2,742 | -3,436 | -1,854 | -3,267 | -516.07 | -383.45 |
Net Debt Issued (Repaid) | -14.68 | -617.27 | -61.51 | -1,114 | 1,761 | -383.45 |
Issuance of Common Stock | - | - | - | 10.86 | - | - |
Repurchase of Common Stock | - | - | -194.98 | - | -242.09 | -257.99 |
Common Dividends Paid | -548.98 | -606.83 | -412.66 | -821.62 | -400.99 | -768.19 |
Other Financing Activities | 25.92 | 44.2 | 191.63 | 139.5 | - | - |
Financing Cash Flow | -537.73 | -1,180 | -477.52 | -1,785 | 1,118 | -1,410 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -32.21 | -6.54 | 3.55 | -1.66 | -0.65 | -1.98 |
Net Cash Flow | 436.73 | 203.62 | -3,320 | 306.52 | 282.21 | -61.12 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 997.62 | 1,018 | 364.87 | 310.26 | 1,784 | 128.42 |
Free Cash Flow Growth | 120.84% | 178.94% | 17.60% | -82.61% | 1289.26% | -96.94% |
Free Cash Flow Margin | 9.05% | 9.29% | 4.06% | 3.79% | 15.72% | 1.60% |
Free Cash Flow Per Share | 1.71 | 1.75 | 0.62 | 0.52 | 3.02 | 0.21 |
Levered Free Cash Flow | 139.12 | 510.98 | 139.01 | -77.54 | 1,329 | -247.08 |
Unlevered Free Cash Flow | 171.67 | 545.43 | 173.3 | -37.89 | 1,361 | -228.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 585.04 | 557.02 | 299.9 | 670.84 | 710.9 | 834.97 |
Change in Working Capital | -86.7 | -86.7 | -264.45 | -386.13 | 414.6 | -704.39 |